1103
L&H
document
June 1, 2012 — 00:00

Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.

L&H
document
June 1, 2012 — 00:00

Urological cancers, i.e. of the kidney, bladder and prostate, have an estimated incidence of about 100,000 new cases each year in France.

L&H
document
May 3, 2012 — 00:00

SCOR Global Life Embedded Value reaches EUR 3.3 billion in 2011 (EUR 18.0 per share), continuing to provide the SCOR group with significant earnings and strong capital repatriation.

document
May 3, 2012 — 00:00

SCOR records net income of EUR 104 million in the 1st quarter 2012, confirming the dynamism of its franchise. SCOR Global Life Embedded Value grows by 50% to EUR 3.3 billion.

L&H
document
April 30, 2012 — 00:00

The introduction of the new European supervisory System, Solvency II, is around the corner, even though now with a modified timetable compared to the initial planning.

L&H
document
April 30, 2012 — 00:00

The introduction of the new European supervisory System, Solvency II, is around the corner, even though now with a modified timetable compared to the initial planning.